GB8514090D0
(en)
*
|
1985-06-04 |
1985-07-10 |
Sandoz Ltd |
Organic compounds
|
JPS61267528A
(ja)
*
|
1984-11-26 |
1986-11-27 |
Yamanouchi Pharmaceut Co Ltd |
吸収促進剤を含有するカルシトニン経鼻剤
|
JPS61137828A
(ja)
*
|
1984-12-07 |
1986-06-25 |
Shionogi & Co Ltd |
γ−インタ−フエロン製剤組成物
|
JPS61194034A
(ja)
*
|
1985-02-25 |
1986-08-28 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
US5643565A
(en)
*
|
1985-09-20 |
1997-07-01 |
Chiron Corporation |
Human IL-2 as a vaccine adjuvant
|
US5503841A
(en)
*
|
1985-09-20 |
1996-04-02 |
Cetus Oncology Corporation |
Human IL-2 as a vaccine adjuvant
|
DE3601923A1
(de)
*
|
1986-01-23 |
1987-07-30 |
Behringwerke Ag |
Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
|
US4734401A
(en)
*
|
1986-03-17 |
1988-03-29 |
W. R. Grace & Co. |
Process for spray drying amino acid compositions
|
DK179286D0
(da)
*
|
1986-04-18 |
1986-04-18 |
Nordisk Gentofte |
Insulinpraeparat
|
CA1291036C
(en)
*
|
1986-04-23 |
1991-10-22 |
Edwin I. Stoltz |
Nasal administration of drugs
|
CA1257199A
(en)
*
|
1986-05-20 |
1989-07-11 |
Paul Y. Wang |
Preparation containing bioactive macromolecular substance for multi-months release in vivo
|
US4962091A
(en)
*
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
HU198626B
(en)
*
|
1986-05-27 |
1989-11-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
|
IT1204400B
(it)
*
|
1986-06-20 |
1989-03-01 |
Sclavo Spa |
Composizioni farmaceutiche contenente una calcitonina
|
DE3726517A1
(de)
*
|
1986-08-18 |
1988-03-03 |
Sandoz Ag |
Nasale zusammensetzungen, welche octreotid enthalten
|
JP2876058B2
(ja)
*
|
1986-08-18 |
1999-03-31 |
エミスフィア・テクノロジーズ・インコーポレイテッド |
薬物送達システム
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
ATE76311T1
(de)
*
|
1986-08-19 |
1992-06-15 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
|
US5075109A
(en)
*
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
US5811128A
(en)
*
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
JPH0688898B2
(ja)
*
|
1986-10-31 |
1994-11-09 |
帝人株式会社 |
アスコルビン酸類を含有する経鼻投与用粉末状組成物
|
JP2505430B2
(ja)
*
|
1986-11-04 |
1996-06-12 |
帝人株式会社 |
塩基性アミノ酸を含有する経鼻投与用粉末状組成物
|
WO1988005661A1
(en)
*
|
1987-01-30 |
1988-08-11 |
Biomed Research Consultants, Limited |
Vasopressin-based pharmaceutical compositions
|
US5690954A
(en)
*
|
1987-05-22 |
1997-11-25 |
Danbiosyst Uk Limited |
Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
|
GB8712176D0
(en)
*
|
1987-05-22 |
1987-06-24 |
Cosmas Damian Ltd |
Drug delivery system
|
IT1222395B
(it)
*
|
1987-07-30 |
1990-09-05 |
Pierrel Spa |
Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
|
US5059587A
(en)
*
|
1987-08-03 |
1991-10-22 |
Toyo Jozo Company, Ltd. |
Physiologically active peptide composition for nasal administration
|
DE3726324A1
(de)
*
|
1987-08-07 |
1989-02-16 |
Hoechst Ag |
Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
|
EP0308181A1
(de)
*
|
1987-09-14 |
1989-03-22 |
Novo Nordisk A/S |
Transmucosale Formulierungen und Verfahren zu ihrer Herstellung
|
IT1222734B
(it)
*
|
1987-09-25 |
1990-09-12 |
Scalvo S P A |
Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
|
GB8723846D0
(en)
*
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
ES2061591T3
(es)
*
|
1987-10-15 |
1994-12-16 |
Syntex Inc |
Administracion intranasal de polipeptidos en forma pulverizada.
|
EP0327756B1
(de)
*
|
1987-11-13 |
1994-01-26 |
Smithkline Beecham Farmaceutici S.p.A. |
Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel
|
FR2634376B1
(fr)
*
|
1988-07-21 |
1992-04-17 |
Farmalyoc |
Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
|
JPH02104531A
(ja)
*
|
1988-10-14 |
1990-04-17 |
Toyo Jozo Co Ltd |
経鼻投与用生理活性ペプチド組成物
|
WO1990005535A1
(en)
*
|
1988-11-14 |
1990-05-31 |
Otsuka Pharmaceutical Co., Ltd. |
Interferon preparation for nasal administration
|
US5567682A
(en)
*
|
1988-12-16 |
1996-10-22 |
Advanced Peptides And Biotechnology Sciences |
Method of treating Alzheimer's disease
|
JP2704546B2
(ja)
*
|
1989-04-04 |
1998-01-26 |
光利 太良 |
Atll治療用吸入剤
|
IT8920486A0
(it)
*
|
1989-05-12 |
1989-05-12 |
Isf Spa |
Composizioni farmaceutiche.
|
GB2237510B
(en)
*
|
1989-11-04 |
1993-09-15 |
Danbiosyst Uk |
Small particle drug compositions for nasal administration
|
US5707644A
(en)
*
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
US6407061B1
(en)
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
US5364840A
(en)
*
|
1989-12-05 |
1994-11-15 |
Vical, Inc. |
Synthetic calcitonin peptides
|
US5175146A
(en)
*
|
1989-12-05 |
1992-12-29 |
Vical, Inc. |
Synthetic calcitonin peptides
|
US5624898A
(en)
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
US5188825A
(en)
*
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
US5376386A
(en)
*
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
GB9001635D0
(en)
*
|
1990-01-24 |
1990-03-21 |
Ganderton David |
Aerosol carriers
|
JPH05963A
(ja)
*
|
1990-04-13 |
1993-01-08 |
Toray Ind Inc |
ポリペプチド類組成物
|
DE69129110T2
(de)
*
|
1990-05-10 |
1998-12-10 |
Bechgaard Int Res |
Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole
|
ATE113469T1
(de)
*
|
1990-06-21 |
1994-11-15 |
Edith Dr Huland |
Verwendung zytokinhaltiger aerosole und zytokinhaltige aerosole selbst.
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US6331318B1
(en)
*
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5714167A
(en)
*
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6099856A
(en)
*
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
IL99699A
(en)
*
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
GB9101592D0
(en)
*
|
1991-01-24 |
1991-03-06 |
Glaxo Group Ltd |
Compositions
|
DK49791D0
(da)
*
|
1991-03-20 |
1991-03-20 |
Novo Nordisk As |
Nasalt pulverpraeparat
|
IT1247472B
(it)
*
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
DE4222647A1
(de)
*
|
1991-07-15 |
1993-01-21 |
Sandoz Ag |
Peptid-zubereitungen
|
WO1993001826A1
(en)
*
|
1991-07-19 |
1993-02-04 |
East Carolina University |
Method of treating asthma
|
RU2054180C1
(ru)
*
|
1991-08-21 |
1996-02-10 |
Жирнов Олег Петрович (н/п) |
Способ лечения вирусных респираторных инфекций
|
US5811127A
(en)
*
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5792451A
(en)
*
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
BR9307141A
(pt)
|
1992-09-29 |
1999-03-30 |
Inhale Therapeutic Syst |
Processo para a liberação sistência pulsátil de um fragmento ativo de hormônio de paratiróide (PTH) para um hospedeiro mamífero e para um paciente e composição farmacêutica
|
US5401516A
(en)
*
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5354934A
(en)
†
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
US5981719A
(en)
*
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
AU692440B2
(en)
*
|
1993-03-11 |
1998-06-11 |
Secretech, Inc. |
Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
|
US5958457A
(en)
*
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5709861A
(en)
*
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5766633A
(en)
*
|
1993-04-22 |
1998-06-16 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5643957A
(en)
*
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
TW402506B
(en)
*
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US5830853A
(en)
*
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
SE9303574D0
(sv)
*
|
1993-11-01 |
1993-11-01 |
Kabi Pharmacia Ab |
Composition for drug delivery and method the manufacturing thereof
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
DE69535897D1
(de)
*
|
1994-03-07 |
2009-01-22 |
Nektar Therapeutics |
Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
|
ES2245780T3
(es)
*
|
1994-05-18 |
2006-01-16 |
Nektar Therapeutics |
Metodos y composiciones para la formulacion de interferones como un polvo seco.
|
US6165976A
(en)
*
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
MX9704550A
(es)
|
1994-12-22 |
1997-10-31 |
Astra Ab |
Formulaciones de medicamentos en aerosol.
|
EP0806945B1
(de)
|
1994-12-22 |
2003-04-23 |
AstraZeneca AB |
Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
DE726075T1
(de)
*
|
1995-02-08 |
1996-12-12 |
Therapicon Srl |
Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
|
BR9604880A
(pt)
*
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
US5866536A
(en)
*
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
*
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
*
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5965121A
(en)
*
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5989539A
(en)
*
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
*
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US6051258A
(en)
*
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US5667806A
(en)
*
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
JP3098401B2
(ja)
*
|
1995-07-12 |
2000-10-16 |
株式会社エルティーティー研究所 |
経鼻投与用製剤
|
WO1997010197A1
(en)
*
|
1995-09-11 |
1997-03-20 |
Emisphere Technologies, Inc. |
METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES
|
JP3263598B2
(ja)
*
|
1995-11-01 |
2002-03-04 |
有限会社ドット |
経鼻吸収用生理活性ペプチド組成物
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
AU722319B2
(en)
|
1996-02-27 |
2000-07-27 |
Teijin Limited |
Powdery composition for nasal administration
|
IL126318A
(en)
|
1996-03-29 |
2004-09-27 |
Emisphere Tech Inc |
Compounds and compositions for delivering active agents and some novel carrier compounds
|
JP2000512671A
(ja)
|
1996-06-14 |
2000-09-26 |
エミスフェアー テクノロジーズ インク |
マイクロカプセル化香料及び調製方法
|
JP3020141B2
(ja)
*
|
1996-10-07 |
2000-03-15 |
株式会社富士薬品 |
経鼻投与用製剤
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US5939381A
(en)
*
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
*
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US6060513A
(en)
*
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5990166A
(en)
*
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
*
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
*
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
GB9707934D0
(en)
*
|
1997-04-18 |
1997-06-04 |
Danbiosyst Uk |
Improved delivery of drugs to mucosal surfaces
|
US5863944A
(en)
*
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
*
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
TWI243687B
(en)
*
|
1998-04-21 |
2005-11-21 |
Teijin Ltd |
Pharmaceutical composition for application to mucosa
|
US6190699B1
(en)
*
|
1998-05-08 |
2001-02-20 |
Nzl Corporation |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
DE19826628C1
(de)
*
|
1998-06-17 |
2000-07-20 |
Werner Kern |
Intranasale Verwendung von Insulin bei Hirnleistungsstörungen
|
AU764331B2
(en)
*
|
1998-07-08 |
2003-08-14 |
Kirin-Amgen Inc. |
Powdery preparation for mucosal administration containing polymeric medicine
|
ES2263282T3
(es)
*
|
1998-08-26 |
2006-12-01 |
Teijin Limited |
Composiciones en polvo para administracion nasal.
|
US7273618B2
(en)
*
|
1998-12-09 |
2007-09-25 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
RU2140285C1
(ru)
*
|
1999-01-25 |
1999-10-27 |
Гапонюк Петр Яковлевич |
Противовирусное средство - капли в нос "гриппферон"
|
US6258857B1
(en)
*
|
1999-02-04 |
2001-07-10 |
Kyowa Industrial Co., Ltd. |
Internal liquid composition contained as internal liquid in a releasing container and releasing container product
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
EP2280020B1
(de)
|
1999-06-29 |
2016-02-17 |
MannKind Corporation |
Pharmazeutische zusammensetzungen enthaltend ein peptid welches mit diketopiperazin komplexiert ist.
|
US6398774B1
(en)
|
1999-09-29 |
2002-06-04 |
Heska Corporation |
Intranasal delivery system
|
US7678087B2
(en)
*
|
1999-09-29 |
2010-03-16 |
Heska Corporation |
Equine intranasal delivery system
|
AR026073A1
(es)
|
1999-10-20 |
2002-12-26 |
Nycomed Gmbh |
Composicion farmaceutica acuosa que contiene ciclesonida
|
KR20020070346A
(ko)
*
|
2000-01-20 |
2002-09-05 |
바실리어 파마슈티카 아게 |
비강 투여 가능 고리형 펩티드 조성물
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
US20030138460A1
(en)
*
|
2000-02-08 |
2003-07-24 |
Allergan, Inc |
Methods of treating animals with botulinum toxin pharmaceutical compositions
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
AU2001233315B2
(en)
*
|
2000-02-08 |
2004-07-08 |
Allergan Sales, Inc. |
Botulinum toxin pharmaceutical compositions
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
WO2001085136A2
(en)
|
2000-05-10 |
2001-11-15 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
GB0011807D0
(en)
*
|
2000-05-16 |
2000-07-05 |
Quadrant Holdings Cambridge |
Formulation for inhalation
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
JP4296341B2
(ja)
*
|
2000-10-13 |
2009-07-15 |
独立行政法人産業技術総合研究所 |
リポソームの製造方法およびその装置
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7244703B2
(en)
*
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
EP1413311A4
(de)
*
|
2001-07-05 |
2005-10-19 |
Translational Res Ltd |
Zusammensetzungen zur nasalen verabreichung von insulin
|
BR0214279A
(pt)
*
|
2001-11-19 |
2005-12-20 |
Becton Dickinson Co |
Composições farmacêuticas em forma particulada
|
TWI324518B
(en)
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
US7666876B2
(en)
*
|
2002-03-19 |
2010-02-23 |
Vernalis (R&D) Limited |
Buprenorphine formulations for intranasal delivery
|
EP1494732B1
(de)
|
2002-03-20 |
2008-01-30 |
MannKind Corporation |
Inhalationsgerät
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
WO2003097080A1
(en)
*
|
2002-05-15 |
2003-11-27 |
Sun Pharmaceutical Industries Limited |
A stable aqueous composition of a peptide
|
US20090035260A1
(en)
*
|
2002-07-29 |
2009-02-05 |
Therapicon Srl |
Enhanced nasal composition of active peptide
|
GB0300531D0
(en)
*
|
2003-01-10 |
2003-02-12 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical compositions
|
US7638138B2
(en)
*
|
2003-02-21 |
2009-12-29 |
Translational Research, Ltd. |
Compositions for nasal administration of pharmaceuticals
|
AU2003220808B2
(en)
|
2003-03-27 |
2008-08-21 |
Bioactis Limited |
Powder medicine applicator for nasal cavity
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
CA2547990C
(en)
|
2003-12-08 |
2011-08-02 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for insulin treatment
|
ITMI20040235A1
(it)
*
|
2004-02-13 |
2004-05-13 |
Therapicon Srl |
Preparazione farmaceutica per il cavo orale
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
JP4922762B2
(ja)
|
2004-08-10 |
2012-04-25 |
株式会社新日本科学 |
速効性でかつ高い吸収性を可能とする経鼻投与用組成物
|
DK1786784T3
(da)
|
2004-08-20 |
2011-02-14 |
Mannkind Corp |
Katalyse af diketopiperazinsyntese
|
PL2322180T3
(pl)
|
2004-08-23 |
2015-10-30 |
Mannkind Corp |
Sole diketopiperazyny do dostarczania leków
|
US7115561B2
(en)
*
|
2004-09-22 |
2006-10-03 |
Patterson James A |
Medicament composition and method of administration
|
GB2420707A
(en)
*
|
2004-10-11 |
2006-06-07 |
Nasaleze Patents Ltd |
Compositions for intranasal administration
|
CN104324366B
(zh)
|
2005-09-14 |
2016-10-05 |
曼金德公司 |
以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
MX360812B
(es)
|
2006-02-22 |
2018-11-16 |
Mannkind Corp |
Un método para mejorar las propiedades farmacéuticas de micropartículas que contienen dicetopiperazina y un agente activo.
|
US8337817B2
(en)
|
2006-12-26 |
2012-12-25 |
Shin Nippon Biomedical Laboratories, Ltd. |
Preparation for transnasal application
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
DE202009018480U1
(de)
|
2008-06-13 |
2012-01-26 |
Mannkind Corp. |
Trockenpulverinhalator und System zur Medikamentenabgabe
|
MX2010014240A
(es)
|
2008-06-20 |
2011-03-25 |
Mankind Corp |
Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
US8538707B2
(en)
|
2009-03-11 |
2013-09-17 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
JP2012526726A
(ja)
|
2009-05-15 |
2012-11-01 |
株式会社新日本科学 |
薬物動態が改善された鼻腔内用薬学的組成物
|
KR101875969B1
(ko)
|
2009-06-12 |
2018-07-06 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
WO2011013003A2
(en)
|
2009-07-31 |
2011-02-03 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal granisetron and nasal applicator
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
US9808030B2
(en)
|
2011-02-11 |
2017-11-07 |
Grain Processing Corporation |
Salt composition
|
BR122020008875B8
(pt)
|
2011-04-01 |
2022-12-06 |
Mannkind Corp |
Embalagem de bolha e método de fabricação de uma embalagem de bolhas
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US9789071B2
(en)
|
2012-06-27 |
2017-10-17 |
G2B Pharma, Inc. |
Intranasal formulation of epinephrine for the treatment of anaphylaxis
|
KR102264177B1
(ko)
|
2012-07-12 |
2021-06-11 |
맨카인드 코포레이션 |
건조 분말 약물 전달 시스템 및 방법
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
PL2964199T3
(pl)
|
2013-03-04 |
2021-01-25 |
Besins Healthcare Luxembourg Sarl |
Suche kompozycje farmaceutyczne zawierające nanocząstki środka aktywnego związane z cząstkami nośnika
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
EP3030294B1
(de)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflationsvorrichtung
|
WO2015034822A1
(en)
*
|
2013-09-03 |
2015-03-12 |
G2B Pharma Inc. |
Intranasal formulation for the treatment of cardiopulmonary resuscitation (cpr), cardiac life support (cls), anaphylaxis and/or anaphylactoid reactions
|
ES2904570T3
(es)
*
|
2013-09-24 |
2022-04-05 |
Satsuma Pharmaceuticals Inc |
Formulación de DHE intranasal para el tratamiento del dolor de cabeza
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
LT3242676T
(lt)
|
2015-01-07 |
2024-01-25 |
Tonix Pharma Limited |
Oksitocino vaistinės formos, kurių sudėtyje yra magnio, ir jų naudojimo būdai
|
US11744967B2
(en)
|
2017-09-26 |
2023-09-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal delivery devices
|
US10758532B2
(en)
|
2018-12-11 |
2020-09-01 |
Satsuma Pharmaceuticals, Inc. |
Compositions, devices, and methods for treating or preventing headaches
|
EP4232006A1
(de)
*
|
2020-12-16 |
2023-08-30 |
LIW Innovation AB |
Neue pulverzusammensetzung
|
WO2023192691A2
(en)
*
|
2022-04-01 |
2023-10-05 |
Wake Forest University Health Sciences |
Methods and formulations for intranasal delivery of insulin in the treatment of diabetic eye disease
|